|
Moving On With Pompe!
|
IPA |
|
Overview of Clinical Trials
|
IPA |
|
Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Study
|
Amicus |
|
New Zealand Rare Disease Day Award 2019 for Allyson Lock
|
Webmaster |
|
2019 IPA Awareness Calendar
|
IPA |
|
Community Advisory Board (CAB) - Call for Applications
|
IPA |
|
Enzyme Replacement Therapy Reduces The Risk For Wheelchair Dependency In Adult Pompe Patients
|
IPA |
|
The Humanistic Burden of Pompe Disease: Are There Still Unmet Needs? A Systematic Review.
|
Audentes |
|
Update on a Clinical Trial (COMET Study by Sanofi Genzyme)
|
Sanofi Genzyme |
|
Obituary to Henri Termeer
|
IPA |
